Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 25%Moderate 3 · 75%High 0 · 0%

Stroke · patients with hypertension

CCBs may leads to lower stroke compared with ACE inhibitor (low certainty).

1 finding from 1 review

Calcium channel blockers versus other classes of drugs for hypertension 2022 · Cochrane Headline outcomes only
RR 0.9 [0.81, 0.99]
7 studies · 27999 participants
Low

Stroke · patients with hypertension

CCBs showed no clear difference in stroke compared with ARB (moderate certainty).

1 finding from 1 review

Calcium channel blockers versus other classes of drugs for hypertension 2022 · Cochrane Headline outcomes only
RR 0.89 [0.76, 1]
6 studies · 25611 participants
Moderate

Stroke · patients with hypertension

CCBs showed no clear difference in stroke compared with diuretic (moderate certainty).

1 finding from 1 review

Calcium channel blockers versus other classes of drugs for hypertension 2022 · Cochrane Headline outcomes only
RR 0.94 [0.84, 1.05]
5 studies · 34072 participants
Moderate

Stroke · patients with hypertension

CCBs probably leads to lower stroke compared with β‐blocker (moderate certainty).

1 finding from 1 review

Calcium channel blockers versus other classes of drugs for hypertension 2022 · Cochrane Headline outcomes only
RR 0.77 [0.67, 0.88]
3 studies · 22249 participants
Moderate